BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8374883)

  • 1. Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer.
    Schöber C; Papageorgiou E; Harstrick A; Bokemeyer C; Mügge A; Stahl M; Wilke H; Poliwoda H; Hiddemann W; Köhne-Wömpner CH
    Cancer; 1993 Oct; 72(7):2242-7. PubMed ID: 8374883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoropyrimidine-associated cardiotoxicity: revisited.
    Saif MW; Shah MM; Shah AR
    Expert Opin Drug Saf; 2009 Mar; 8(2):191-202. PubMed ID: 19309247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotoxicity of de Gramont's regimen: incidence, clinical characteristics and long-term follow-up.
    Meydan N; Kundak I; Yavuzsen T; Oztop I; Barutca S; Yilmaz U; Alakavuklar MN
    Jpn J Clin Oncol; 2005 May; 35(5):265-70. PubMed ID: 15855175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical cardiotoxicity of 5-fluorouracil.
    Keefe DL; Roistacher N; Pierri MK
    J Clin Pharmacol; 1993 Nov; 33(11):1060-70. PubMed ID: 8300889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.
    Jäger E; Heike M; Bernhard H; Klein O; Bernhard G; Lautz D; Michaelis J; Meyer zum Büschenfelde KH; Knuth A
    J Clin Oncol; 1996 Aug; 14(8):2274-9. PubMed ID: 8708717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancer.
    Hartung G; Hofheinz RD; Wein A; Riedel C; Rost A; Fritze D; Kreuser ED; Drees M; Kühnel J; Hehlmann R; Queisser W
    Onkologie; 2001 Oct; 24(5):457-62. PubMed ID: 11694772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate nephropathy occurring during cytotoxic chemotherapy with high-dose folinic acid and 5-fluorouracil.
    Metz-Kurschel U; Kurschel E; Wagner K; Aulbert E; Graben N; Philipp T
    Ren Fail; 1990; 12(2):93-7. PubMed ID: 2236732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronomodulated chemotherapy with oxaliplatin, 5-FU and sodium folinate in metastatic gastrointestinal cancer patients: original analysis of non-hematological toxicity and patient characteristics in a pilot investigation.
    Farker K; Merkel U; Wedding U; Hippius M; Höffken K; Hoffmann A
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):31-7. PubMed ID: 16425969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe cardiotoxicity of high-dose 5-fluorouracil in combination with folinic acid, cisplatin and methotrexate in a 14-year-old boy with nasopharyngeal carcinoma (Schmincke tumor).
    Blütters-Sawatzki R; Grathwohl J; Mertens R; Lampert F
    Oncology; 1995; 52(4):291-4. PubMed ID: 7777242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronotherapy with 5-fluorouracil and folinic acid in advanced colorectal carcinoma. Results of a chronopharmacologic phase I trial.
    Adler S; Lang S; Langenmayer I; Eibl-Eibesfeldt B; Rump W; Emmerich B; Hallek M
    Cancer; 1994 Jun; 73(12):2905-12. PubMed ID: 8199987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study.
    Peng J; Dong C; Wang C; Li W; Yu H; Zhang M; Zhao Q; Zhu B; Zhang J; Li W; Wang F; Wu Q; Zhou W; Yuan Y; Qiu M; Chen G
    Cancer Commun (Lond); 2018 May; 38(1):22. PubMed ID: 29764506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
    Polyzos A; Tsavaris N; Giannopoulos A; Bacoyiannis C; Papadimas V; Kalahanis N; Karatzas G; Kosmas C; Sakelaropoulos N; Archimandritis A; Papachristodoulou A; Kosmidis P
    Cancer Chemother Pharmacol; 1996; 38(3):292-7. PubMed ID: 8646806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cardiotoxicity of a combined bolus plus infusional 5-fluorouracil/folinic acid treatment by echocardiography, plasma troponin I level, QT interval and dispersion in patients with gastrointestinal system cancers.
    Oztop I; Gencer M; Okan T; Yaren A; Altekin E; Turker S; Yilmaz U
    Jpn J Clin Oncol; 2004 May; 34(5):262-8. PubMed ID: 15231861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of orally administered dipyridamole to enhance the antineoplastic activity of fluorouracil in combination with leucovorin in patients with advanced colorectal cancer: a prospective randomized trial.
    Köhne CH; Hiddemann W; Schüller J; Weiss J; Lohrmann HP; Schmitz-Hübner U; Bodenstein H; Schöber C; Wilke H; Grem J
    J Clin Oncol; 1995 May; 13(5):1201-8. PubMed ID: 7738622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study.
    de Forni M; Malet-Martino MC; Jaillais P; Shubinski RE; Bachaud JM; Lemaire L; Canal P; Chevreau C; Carrié D; Soulié P
    J Clin Oncol; 1992 Nov; 10(11):1795-801. PubMed ID: 1403060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose continuous infusion folinic acid and bolus 5-fluorouracil in patients with advanced colorectal cancer: a phase II study.
    Bertrand M; Doroshow JH; Multhauf P; Blayney DW; Carr BI; Cecchi G; Goldberg D; Leong L; Margolin K; Metter G
    J Clin Oncol; 1986 Jul; 4(7):1058-61. PubMed ID: 3487626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant radio-chemotherapy in stage II-III rectal cancer with 24-hour infusion of high-dose 5-fluorouracil and folinic acid: evaluation of feasibility.
    Dencausse Y; Sturm J; Hartung G; Dietzler P; Edler L; Bambach M; Wojatschek C; Lindemann H; Qeisser W
    Onkologie; 2001 Oct; 24(5):476-80. PubMed ID: 11694775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase III study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer.
    Jones DV; Winn RJ; Brown BW; Levy LB; Pugh RP; Wade JL; Gross HM; Pendergrass KB; Levin B; Abbruzzese JL
    Cancer; 1995 Nov; 76(10):1709-14. PubMed ID: 8625038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weekly 24-h infusion of high-dose 5-fluorouracil (5-FU) with folinic acid (FA) in adjuvant therapy of colon cancer.
    Wein A; Riedel C; Brückl W; Kastl S; Reingruber B; Hohenberger W; Hahn EG
    Z Gastroenterol; 2001 Feb; 39(2):153-6. PubMed ID: 11253506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.